• Risk Assessment: Experts Slam Inconclusive German Glyphosate

    By -

    Glyphosate in an active substance widely used in herbicides and is currently subject to a comprehensive re-evaluation process by the European Union (EU). This regular re-assessment of active ingredients in plant protection products is a routine procedure controlled by the European Commission. Within this re-evaluation new findings in research and development as well as new aspects in the risk assessment are taken into consideration. As a result of this re-evaluation, the Commission will decide whether or not the active substance may be applied in plant protection products in future.

    In a report published Friday, Testbiotech is highlighting the ongoing inadequacies in the risk assessment of the herbicide, glyphosate. The weed killer is sold under brand names such as Roundup.

    In contrast to these findings, the Testbiotech analysis shows that the German assessment report is untenable in light of new scientific evidence and cites evidence from studies published in 2013 and 2014. Testbiotech concluded that risks associated with glyphosate must be examined much more closely than has been the case so far.

    Several studies showed a significant effect on the hormonal system in mammals. Further, a recent study indicated for the first time that the learning behaviour of bees can be affected by glyphosate. All these risks were classified as irrelevant by the German authorities. The glyphosate assessment report submitted by the German authorities is currently being considered by the EU Member States and the European Food Safety Authority (EFSA) and a …

    In the case of glyphosate, Germany is the Rapporteur Member State (RMS) who has submitted the draft of the re-evaluation report to the European Food Safety Authority (EFSA). In conclusion of the re-evaluation process by BfR, the available data confirms the previous evaluation: Glyphosate does not show carcinogenic or mutagenic properties, has no toxic effect on fertility, reproduction or embryonal/fetal development in laboratory animals and is not considered to pose any risk to human health. The sub report by BfR is now available for consultation with interested stakeholders and will go into the “peer review procedure” by experts from other EU Member States.

    Please Read this Article at



    Leave a Reply

    Your email address will not be published. Required fields are marked *